PharmAla Announces Voting Results of Annual General and Special Meeting of Shareholders and Provides Corporate Update
The Company is pleased to announce the voting results from its annual general and special meeting of the shareholders of the Company (“Shareholders”) held on Tuesday, February 27, 2024 (the “Meeting”).
- The Company is pleased to announce the voting results from its annual general and special meeting of the shareholders of the Company (“Shareholders”) held on Tuesday, February 27, 2024 (the “Meeting”).
- Shareholders voted in favour of each resolution put forth at the Meeting.
- “PharmAla continues to make the important choices necessary for the future of both our business, and the Psychedelic Pharmaceuticals sector more broadly,” said Jodi Butts, Board Chair, PharmAla Biotech.
- “We are grateful that PharmAla’s shareholders have agreed with management’s recommendations on a variety of timely corporate governance matters.